Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan A Smith

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Journal of Medical Screening|March 18, 2021
Impact of COVID-19-related care disruptions on cervical cancer screening in the United StatesEmily A Burger, Erik El Jansen, James Killen, et al.
JMIR Research Protocols|May 17, 2023
The Indigenous Australian Human Papillomavirus (HPV) Cohort Study 2, Continuation for 5 to 10 Years: Protocol for a Longitudinal StudyJoanne Hedges, Sneha Sethi, Gail Garvey, et al.
Tumour Virus Research|February 3, 2023
Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screeningLouiza S Velentzis, David Hawkes, Michael Caruana, et al.
Journal of Lower Genital Tract Disease|December 20, 2024
How Does Transitioning to Primary Human Papillomavirus Screening Impact Colposcopy Services? Lessons From an Australian National ProgramChloe J Jennett, Megan A Smith, Dorothy A Machalek, et al.
Preventive Medicine|May 24, 2021
Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysisMegan A Smith, Emily A Burger, Alejandra Castanon, et al.
JAMA Network Open|March 12, 2025
Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer ScreeningShalini L Kulasingam, Inge M C M de Kok, Abhinav Mehta, et al.
Lancet Regional Health. Americas|April 23, 2026
Optimal cervical cancer screening strategies for unvaccinated and HPV-vaccinated cohorts in the United States: a comprehensive comparative modeling analysisDaniël D de Bondt, Kate T Simms, Emi Naslazi, et al.
BMC Cancer|June 15, 2011
Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling studyJu-Fang Shi, Karen Canfell, Jie-Bin Lew, et al.
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|September 25, 2023
Tissue-Like 3D Standard and Protocols for Microscope Quality ManagementBenjamin Abrams, Thomas Pengo, Tse-Luen Wee, et al.
Cancer Epidemiology|November 5, 2013
Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007Freddy Sitas, Alison Gibberd, Clare Kahn, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Journal of Medical Screening|March 18, 2021
Impact of COVID-19-related care disruptions on cervical cancer screening in the United StatesEmily A Burger, Erik El Jansen, James Killen, et al.
JMIR Research Protocols|May 17, 2023
The Indigenous Australian Human Papillomavirus (HPV) Cohort Study 2, Continuation for 5 to 10 Years: Protocol for a Longitudinal StudyJoanne Hedges, Sneha Sethi, Gail Garvey, et al.
Tumour Virus Research|February 3, 2023
Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screeningLouiza S Velentzis, David Hawkes, Michael Caruana, et al.
Journal of Lower Genital Tract Disease|December 20, 2024
How Does Transitioning to Primary Human Papillomavirus Screening Impact Colposcopy Services? Lessons From an Australian National ProgramChloe J Jennett, Megan A Smith, Dorothy A Machalek, et al.
Preventive Medicine|May 24, 2021
Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysisMegan A Smith, Emily A Burger, Alejandra Castanon, et al.
JAMA Network Open|March 12, 2025
Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer ScreeningShalini L Kulasingam, Inge M C M de Kok, Abhinav Mehta, et al.
Lancet Regional Health. Americas|April 23, 2026
Optimal cervical cancer screening strategies for unvaccinated and HPV-vaccinated cohorts in the United States: a comprehensive comparative modeling analysisDaniël D de Bondt, Kate T Simms, Emi Naslazi, et al.
BMC Cancer|June 15, 2011
Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling studyJu-Fang Shi, Karen Canfell, Jie-Bin Lew, et al.
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|September 25, 2023
Tissue-Like 3D Standard and Protocols for Microscope Quality ManagementBenjamin Abrams, Thomas Pengo, Tse-Luen Wee, et al.
Cancer Epidemiology|November 5, 2013
Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007Freddy Sitas, Alison Gibberd, Clare Kahn, et al.
Pageof 10